107 related articles for article (PubMed ID: 8536790)
1. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
Sato S; Tomoyasu S; Okabe-Kado J; Hozumi M; Tsuruoka N; Nakai S; Adachi M; Honma Y
Exp Hematol; 1996 Jan; 24(1):37-42. PubMed ID: 8536790
[TBL] [Abstract][Full Text] [Related]
2. Effects of vesnarinone on the bone marrow stromal cell-dependent proliferation and differentiation of HL60 cells in vitro.
Nabeshima R; Aizawa S; Nakano M; Toyama K; Sugimoto K; Kaidow A; Imai T; Handa H
Exp Hematol; 1997 Jun; 25(6):509-15. PubMed ID: 9197329
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).
Isaka K; Fujito A; Sagawa Y; Yudate T; Nishi H; Ito H; Takayama M
Oncol Rep; 2002; 9(6):1299-305. PubMed ID: 12375038
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
5. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
6. Effects of novel uracil analogs on proliferation and differentiation of human myeloid leukemia cells.
Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Ishikawa I; Ogura H; Motoyoshi K
Exp Hematol; 1992 Aug; 20(7):879-85. PubMed ID: 1321051
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Tsuruo T
Cancer Res; 1991 May; 51(10):2582-6. PubMed ID: 1673636
[TBL] [Abstract][Full Text] [Related]
8. Vesnarinone exhibits antitumor effect against myeloid leukemia cells via apoptosis.
Fujiwara H; Arima N; Otsubo H; Matsushita K; Hidaka S; Arimura K; Kukita T; Yamaguchi K; Tanaka H
Exp Hematol; 1997 Oct; 25(11):1180-6. PubMed ID: 9328455
[TBL] [Abstract][Full Text] [Related]
9. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
Niitsu N; Umeda M; Honma Y
Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460
[TBL] [Abstract][Full Text] [Related]
10. An anticancer drug-sensitive murine erythroleukemia clone: implications for the mechanism of action of antineoplastic drugs.
Dinnen RD; Robinow CF; Ebisuzaki K
Cancer Res; 1993 Apr; 53(8):1877-82. PubMed ID: 8467509
[TBL] [Abstract][Full Text] [Related]
11. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
12. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
Jing Y; Hellinger N; Xia L; Monks A; Sausville EA; Zelent A; Waxman S
Cancer Res; 2005 Sep; 65(17):7847-55. PubMed ID: 16140954
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of anticancer effects of radiation and conventional anticancer agents by a quinolinone derivative, vesnarinone: studies on human gastric cancer tissue xenografts in nude mice.
Kawai K; Konishi Y; Izumi K; Sato M; Adachi M; Hozumi M
Anticancer Res; 1998; 18(1A):405-12. PubMed ID: 9568110
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line.
Omotehara F; Nakashiro K; Uchida D; Hino S; Fujimori T; Kawamata H
J Exp Clin Cancer Res; 2003 Mar; 22(1):57-60. PubMed ID: 12725323
[TBL] [Abstract][Full Text] [Related]
15. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
Fuchs R; Stelzer I; Haas HS; Leitinger G; Schauenstein K; Sadjak A
Ann Hematol; 2009 Oct; 88(10):989-97. PubMed ID: 19241077
[TBL] [Abstract][Full Text] [Related]
16. Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell line.
Catani L; Gugliotta L; Motta M; Tazzari P; Baravelli S; Tura S
Haematologica; 1998 May; 83(5):385-91. PubMed ID: 9658720
[TBL] [Abstract][Full Text] [Related]
17. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
Gallagher AP; Burnett AK; Bowen DT; Darley RL
Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
[TBL] [Abstract][Full Text] [Related]
18. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
19. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells.
Beneytout JL; Nappez C; Leboutet MJ; Malinvaud G
Biochem Biophys Res Commun; 1995 Feb; 207(1):398-404. PubMed ID: 7857294
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
Kubo K; Matsuzaki Y; Kato A; Terai S; Okita K
Int J Oncol; 1999 Jan; 14(1):41-6. PubMed ID: 9863007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
